Research on advanced intervention using novel bone marrOW stem cell (RAINBOW): a study protocol for a phase I, open-label, uncontrolled, dose-response trial of autologous bone marrow stromal cell transplantation in patients with acute ischemic stroke
Hideo Shichinohe(Hokkaido University), Kiyohiro Houkin(Hokkaido University), Tuyoshi Teramoto(Hokkaido University Hospital), Takeo Abumiya(Hokkaido University), Teruyo Arato(Hokkaido University Hospital), Naoki Nakayama(Kumamoto University), Masahito Kawabori(Hokkaido University), Hiroaki Iijima(Hokkaido University), Shunsuke Terasaka(Hokkaido University), Ken Kazumata(Hokkaido University)
Cited by 56
Related Papers
Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral Ischemia
|Journal of Cerebral Blood Flow & Metabolism|1999|552
Triggering Receptor Expressed on Myeloid Cells 2 (TREM2) Deficiency Attenuates Phagocytic Activities of Microglia and Exacerbates Ischemic Damage in Experimental Stroke
|Journal of Neuroscience|2015|375
Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised controlled trial
|The Lancet Neurology|2019|216
Activated Microvessels Express Vascular Endothelial Growth Factor and Integrin α <sub>v</sub> β <sub>3</sub> During Focal Cerebral Ischemia
|Journal of Cerebral Blood Flow & Metabolism|1999|155
Rapid Loss of Microvascular Integrin Expression during Focal Brain Ischemia Reflects Neuron Injury
|Journal of Cerebral Blood Flow & Metabolism|2001|141